HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao-Yan Zhou Selected Research

methyl ester 5(S),6(R)-7-trihydroxyheptanoic acid

1/2019BML-111, a lipoxin receptor agonist, protects against acute injury via regulating the renin angiotensin-aldosterone system.
10/2013BML-11, a lipoxin receptor agonist, protected carbon tetrachloride-induced hepatic fibrosis in rats.
9/2009Lipoxin A(4) inhibited hepatocyte growth factor-induced invasion of human hepatoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao-Yan Zhou Research Topics

Disease

32Neoplasms (Cancer)
02/2024 - 12/2007
15Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 01/2005
9Neoplasm Metastasis (Metastasis)
07/2023 - 06/2007
7Inflammation (Inflammations)
01/2024 - 03/2013
7Stomach Neoplasms (Stomach Cancer)
02/2021 - 08/2011
6Breast Neoplasms (Breast Cancer)
02/2024 - 01/2012
5Carcinogenesis
12/2015 - 02/2008
4Colorectal Neoplasms (Colorectal Cancer)
07/2023 - 11/2005
4Carcinoma (Carcinomatosis)
06/2018 - 01/2013
4Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2013 - 01/2008
3Hypoxia (Hypoxemia)
03/2023 - 09/2015
3B-Cell Lymphoma (Lymphoma, B Cell)
03/2023 - 01/2017
3Fibrosis (Cirrhosis)
04/2021 - 10/2013
3Sepsis (Septicemia)
02/2021 - 03/2018
3Seizures (Absence Seizure)
07/2018 - 12/2017
3Hypothermia
07/2018 - 12/2017
3Ischemia
03/2016 - 02/2010
2Edema (Dropsy)
03/2024 - 01/2022
2Ischemic Stroke
12/2023 - 01/2020
2Microsatellite Instability
07/2023 - 12/2007
2Epstein-Barr Virus Infections
02/2021 - 07/2015
2Lymphoma (Lymphomas)
01/2021 - 01/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 02/2019
2Sepsis-Associated Encephalopathy
02/2019 - 03/2018
2Acute Lung Injury
01/2019 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2018 - 09/2009
2Stroke (Strokes)
01/2018 - 12/2017
2Parkinson Disease (Parkinson's Disease)
10/2017 - 08/2016
2Neuroblastoma
10/2017 - 09/2015
2Asthma (Bronchial Asthma)
01/2017 - 01/2014
2Urinary Bladder Neoplasms (Bladder Cancer)
09/2015 - 01/2008
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2014 - 07/2013
2Lymphatic Metastasis
07/2013 - 01/2008
2Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2013 - 01/2012
2Prostatic Neoplasms (Prostate Cancer)
01/2013 - 09/2008
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
12/2007 - 01/2005
2Hyperplasia
01/2005 - 06/2004
1Exanthema (Rash)
02/2024
1Drug Eruptions (Drug Eruption)
02/2024
1Cardiovascular Diseases (Cardiovascular Disease)
01/2024
1Glioma (Gliomas)
01/2024
1Inborn Genetic Diseases (Disease, Hereditary)
11/2023
1Thalassemia
11/2023

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2008
9Messenger RNA (mRNA)IBA
03/2023 - 11/2005
6Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2008
5Glucose (Dextrose)FDA LinkGeneric
03/2023 - 12/2014
5CytokinesIBA
01/2022 - 03/2013
5LipoxinsIBA
10/2019 - 09/2009
4RNA (Ribonucleic Acid)IBA
01/2024 - 12/2014
4Formaldehyde (Formol)FDA Link
01/2024 - 01/2020
4ParaffinIBA
01/2024 - 01/2020
4DNA (Deoxyribonucleic Acid)IBA
11/2023 - 06/2004
4MicroRNAs (MicroRNA)IBA
10/2017 - 01/2013
3Transcription Factors (Transcription Factor)IBA
01/2024 - 08/2011
3NucleotidesIBA
11/2023 - 01/2013
3LipopolysaccharidesIBA
01/2022 - 08/2014
3B7-H1 AntigenIBA
01/2021 - 12/2018
3methyl ester 5(S),6(R)-7-trihydroxyheptanoic acidIBA
01/2019 - 09/2009
3CateninsIBA
01/2018 - 08/2011
3Long Noncoding RNAIBA
01/2018 - 12/2014
2human ERBB2 proteinIBA
02/2024 - 01/2017
2Peptides (Polypeptides)IBA
12/2023 - 01/2022
2Receptor for Advanced Glycation End ProductsIBA
12/2023 - 01/2022
2TOR Serine-Threonine KinasesIBA
03/2023 - 11/2013
2Phosphatidylinositols (Phosphatidylinositol)IBA
03/2023 - 10/2018
2AntigensIBA
12/2022 - 01/2020
2Rituximab (Mabthera)FDA Link
12/2020 - 04/2017
2Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020 - 03/2016
2ibrutinibIBA
10/2019 - 06/2018
22'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
07/2018 - 12/2017
2Interleukin-6 (Interleukin 6)IBA
01/2018 - 03/2013
2lipoxin A4IBA
01/2018 - 08/2014
2Indicators and Reagents (Reagents)IBA
09/2015 - 12/2014
2ErbB Receptors (EGF Receptor)IBA
04/2014 - 09/2008
2PlatinumIBA
04/2013 - 01/2012
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2013 - 01/2012
2Paclitaxel (Taxol)FDA LinkGeneric
01/2012 - 09/2008
2MutL Protein Homolog 1IBA
12/2008 - 12/2007
1Interleukin-4 (Interleukin 4)IBA
02/2024
1Interleukin-13IBA
02/2024
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2024
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2024
1Tryptophan (L-Tryptophan)FDA Link
01/2024
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2024
1Arachidonic Acid (Vitamin F)IBA
01/2024
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2024
1Calcium-Binding ProteinsIBA
12/2023
1ProhibitinsIBA
11/2023
1Hemoglobin A2IBA
11/2023
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2023
1GlobinsIBA
11/2023
1Calcibiotic Root Canal SealerIBA
07/2023
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
03/2023
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
03/2023
1AMP-Activated Protein KinasesIBA
03/2023

Therapy/Procedure

10Therapeutics
02/2021 - 01/2008
3Drug Therapy (Chemotherapy)
01/2023 - 01/2012
3Radiotherapy
01/2019 - 01/2008
1Neoadjuvant Therapy
02/2024